Syantra: Rob Lozuk

Calgary, Alberta-based liquid biopsy company Syantra has appointed Rob Lozuk as CEO. Lozuk was previously chief business officer at Cardea Bio, which was acquired by Paragraf in 2023. He has also served as president of Specific Diagnostics, which was acquired by BioMérieux in 2022. Lozuk has also previously held leadership positions at Sequenom and Thermo Fisher Scientific. Lozuk will take the reins at Syantra as it prepares to commercialize its CE-marked Syantra DX Breast Cancer test in the US.